| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | small GTPase binding | 4.83e-06 | 321 | 100 | 10 | GO:0031267 | |
| GeneOntologyMolecularFunction | GTPase binding | 1.31e-05 | 360 | 100 | 10 | GO:0051020 | |
| GeneOntologyBiologicalProcess | protein retention in Golgi apparatus | 1.10e-06 | 5 | 100 | 3 | GO:0045053 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | ABCC4 ARHGAP24 FGD2 MKS1 EHD4 FSIP2 CELSR2 DNAH17 SYNE2 EHD1 ULK4 IFT122 FGD6 HYDIN | 4.27e-06 | 670 | 100 | 14 | GO:0120031 |
| GeneOntologyBiologicalProcess | cell projection assembly | ABCC4 ARHGAP24 FGD2 MKS1 EHD4 FSIP2 CELSR2 DNAH17 SYNE2 EHD1 ULK4 IFT122 FGD6 HYDIN | 5.50e-06 | 685 | 100 | 14 | GO:0030031 |
| GeneOntologyBiologicalProcess | cilium assembly | ABCC4 MKS1 EHD4 FSIP2 CELSR2 DNAH17 SYNE2 EHD1 ULK4 IFT122 HYDIN | 1.03e-05 | 444 | 100 | 11 | GO:0060271 |
| GeneOntologyBiologicalProcess | cilium organization | ABCC4 MKS1 EHD4 FSIP2 CELSR2 DNAH17 SYNE2 EHD1 ULK4 IFT122 HYDIN | 1.97e-05 | 476 | 100 | 11 | GO:0044782 |
| GeneOntologyBiologicalProcess | regulation of angiotensin metabolic process | 6.96e-05 | 3 | 100 | 2 | GO:0060177 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | FSIP2 CELSR2 DNAH17 SYNE2 VPS13A ULK4 IFT122 TRAK2 HYDIN KIF22 | 1.41e-04 | 493 | 100 | 10 | GO:0007018 |
| GeneOntologyBiologicalProcess | peptide catabolic process | 1.82e-04 | 23 | 100 | 3 | GO:0043171 | |
| GeneOntologyCellularComponent | early endosome | 1.03e-04 | 481 | 100 | 10 | GO:0005769 | |
| Domain | ARM-type_fold | 1.39e-05 | 339 | 100 | 10 | IPR016024 | |
| Domain | VPS13 | 8.48e-05 | 3 | 100 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 8.48e-05 | 3 | 100 | 2 | PF16910 | |
| Domain | VPS13 | 8.48e-05 | 3 | 100 | 2 | PF16908 | |
| Domain | VPS13_N2 | 8.48e-05 | 3 | 100 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 8.48e-05 | 3 | 100 | 2 | IPR031642 | |
| Domain | DUF21 | 1.69e-04 | 4 | 100 | 2 | IPR002550 | |
| Domain | SHR-BD | 1.69e-04 | 4 | 100 | 2 | IPR009543 | |
| Domain | VPS13_C | 1.69e-04 | 4 | 100 | 2 | PF16909 | |
| Domain | VPS13_C | 1.69e-04 | 4 | 100 | 2 | IPR031645 | |
| Domain | DUF21 | 1.69e-04 | 4 | 100 | 2 | PF01595 | |
| Domain | SHR-BD | 1.69e-04 | 4 | 100 | 2 | PF06650 | |
| Domain | Anaphylatoxin_comp_syst | 2.81e-04 | 5 | 100 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 2.81e-04 | 5 | 100 | 2 | IPR001840 | |
| Domain | EHD_N | 2.81e-04 | 5 | 100 | 2 | IPR031692 | |
| Domain | EHD_N | 2.81e-04 | 5 | 100 | 2 | PF16880 | |
| Domain | FYVE | 4.92e-04 | 29 | 100 | 3 | PF01363 | |
| Domain | FYVE | 4.92e-04 | 29 | 100 | 3 | SM00064 | |
| Domain | ANATO | 5.86e-04 | 7 | 100 | 2 | SM00104 | |
| Domain | ANAPHYLATOXIN_2 | 5.86e-04 | 7 | 100 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 5.86e-04 | 7 | 100 | 2 | PS01177 | |
| Domain | ANATO | 5.86e-04 | 7 | 100 | 2 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 5.86e-04 | 7 | 100 | 2 | IPR000020 | |
| Domain | ARM-like | 6.22e-04 | 270 | 100 | 7 | IPR011989 | |
| Domain | ERAP1-like_C_dom | 7.78e-04 | 8 | 100 | 2 | IPR024571 | |
| Domain | Chorein_N | 7.78e-04 | 8 | 100 | 2 | PF12624 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 7.78e-04 | 8 | 100 | 2 | IPR019565 | |
| Domain | VPS13_N | 7.78e-04 | 8 | 100 | 2 | IPR026854 | |
| Domain | ERAP1_C | 7.78e-04 | 8 | 100 | 2 | PF11838 | |
| Domain | Thiol-ester_cl | 7.78e-04 | 8 | 100 | 2 | PF10569 | |
| Domain | MacrogloblnA2_CS | 7.78e-04 | 8 | 100 | 2 | IPR019742 | |
| Domain | Znf_FYVE-rel | 7.90e-04 | 34 | 100 | 3 | IPR017455 | |
| Domain | Znf_FYVE | 1.10e-03 | 38 | 100 | 3 | IPR000306 | |
| Domain | A2M | 1.24e-03 | 10 | 100 | 2 | PF00207 | |
| Domain | A2M_N_2 | 1.24e-03 | 10 | 100 | 2 | IPR011625 | |
| Domain | A2M_comp | 1.24e-03 | 10 | 100 | 2 | IPR011626 | |
| Domain | A2M_recep | 1.24e-03 | 10 | 100 | 2 | PF07677 | |
| Domain | A2M_comp | 1.24e-03 | 10 | 100 | 2 | PF07678 | |
| Domain | A2M_N | 1.24e-03 | 10 | 100 | 2 | PF01835 | |
| Domain | A2M_N | 1.24e-03 | 10 | 100 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.24e-03 | 10 | 100 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.24e-03 | 10 | 100 | 2 | PS00477 | |
| Domain | EF-hand_4 | 1.24e-03 | 10 | 100 | 2 | PF12763 | |
| Domain | A2M_N_2 | 1.24e-03 | 10 | 100 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 1.24e-03 | 10 | 100 | 2 | IPR001599 | |
| Domain | ZF_FYVE | 1.27e-03 | 40 | 100 | 3 | PS50178 | |
| Domain | GAIN_dom_N | 1.51e-03 | 11 | 100 | 2 | IPR032471 | |
| Domain | EH | 1.51e-03 | 11 | 100 | 2 | PS50031 | |
| Domain | GAIN | 1.51e-03 | 11 | 100 | 2 | PF16489 | |
| Domain | EH | 1.51e-03 | 11 | 100 | 2 | SM00027 | |
| Domain | EH_dom | 1.51e-03 | 11 | 100 | 2 | IPR000261 | |
| Domain | Peptidase_M1 | 1.81e-03 | 12 | 100 | 2 | IPR001930 | |
| Domain | ZINC_PROTEASE | 1.90e-03 | 98 | 100 | 4 | PS00142 | |
| Domain | Peptidase_M1_N | 2.13e-03 | 13 | 100 | 2 | IPR014782 | |
| Domain | Peptidase_M1 | 2.13e-03 | 13 | 100 | 2 | PF01433 | |
| Domain | G_DYNAMIN_dom | 2.48e-03 | 14 | 100 | 2 | IPR030381 | |
| Domain | G_DYNAMIN_2 | 2.48e-03 | 14 | 100 | 2 | PS51718 | |
| Domain | Dynamin_GTPase | 2.85e-03 | 15 | 100 | 2 | IPR001401 | |
| Domain | Dynamin_SF | 2.85e-03 | 15 | 100 | 2 | IPR022812 | |
| Domain | Dynamin_N | 2.85e-03 | 15 | 100 | 2 | PF00350 | |
| Domain | C345C | 3.66e-03 | 17 | 100 | 2 | SM00643 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 4.11e-03 | 18 | 100 | 2 | IPR008930 | |
| Domain | NTR | 4.57e-03 | 19 | 100 | 2 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 4.57e-03 | 19 | 100 | 2 | IPR018933 | |
| Domain | TSP_1 | 4.69e-03 | 63 | 100 | 3 | PF00090 | |
| Domain | CBS_dom | 5.06e-03 | 20 | 100 | 2 | IPR000644 | |
| Domain | CBS | 5.06e-03 | 20 | 100 | 2 | PF00571 | |
| Domain | CBS | 5.06e-03 | 20 | 100 | 2 | PS51371 | |
| Domain | TSP1 | 5.12e-03 | 65 | 100 | 3 | SM00209 | |
| Domain | TSP1_rpt | 5.12e-03 | 65 | 100 | 3 | IPR000884 | |
| Domain | TSP1 | 5.12e-03 | 65 | 100 | 3 | PS50092 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 7.96e-05 | 123 | 82 | 6 | MM14623 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 9.09e-05 | 126 | 82 | 6 | M695 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 1.22e-04 | 17 | 82 | 3 | MM15944 | |
| Pubmed | CLTCL1 IPO8 POLD1 PSMA2 XPO4 FARSB PSME2 TUBGCP2 EHD4 NUP205 SYNE2 VPS35 EHD1 ANP32A EIF3D ALDH3A2 CPVL STAG2 MRPL1 | 3.03e-08 | 1440 | 101 | 19 | 30833792 | |
| Pubmed | ABCC4 CLTCL1 POLD1 FARSB PSME2 HMMR TUBGCP2 NCDN EHD4 NUP205 LNPEP PI4KA EHD1 IFT122 EIF3D SLC29A1 STAG2 | 4.39e-08 | 1168 | 101 | 17 | 19946888 | |
| Pubmed | IPO8 POLD1 HMMR NCDN EHD4 SH3BP4 AIFM2 SACS ERAP2 LNPEP PI4KA SF3B6 SYNE2 VPS35 VPS13A ANKRD11 IFT122 ALDH3A2 MRPL1 | 5.01e-08 | 1487 | 101 | 19 | 33957083 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | CNNM2 RNGTT IPO8 POLD1 PSMA2 XPO4 FARSB NUP205 MTMR4 LNPEP SHCBP1 VPS35 ALDH3A2 CPVL SORL1 | 1.45e-07 | 974 | 101 | 15 | 28675297 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ACACB POLD1 HMMR USP9Y VPS13D VPS35 MEPCE ANKRD11 C4A C4B HYDIN | 2.27e-07 | 497 | 101 | 11 | 36774506 |
| Pubmed | ABCC4 SH3BP4 VPS13D LNPEP PI4KA SYNE2 VPS35 VPS13A GCC1 ALDH3A2 SLC29A1 | 2.61e-07 | 504 | 101 | 11 | 34432599 | |
| Pubmed | SETX HMMR NCDN SH3BP4 AIFM2 PSME4 SHCBP1 C4A C4B IFT122 IQGAP3 SORL1 | 4.31e-07 | 650 | 101 | 12 | 38777146 | |
| Pubmed | RNGTT IPO8 PSMA2 MRPL55 FARSB PSME2 NCDN MORF4L1 ANP32A EIF3D ALDH3A2 IQGAP3 MRPL1 KIF22 | 8.59e-07 | 971 | 101 | 14 | 33306668 | |
| Pubmed | 1.78e-06 | 282 | 101 | 8 | 23667531 | ||
| Pubmed | ARHGAP24 IPO8 FGD2 PSMA2 ARHGEF10L NUP205 SF3B6 SHCBP1 ANP32A EIF3D CPVL FGD6 SORL1 | 2.60e-06 | 916 | 101 | 13 | 32203420 | |
| Pubmed | TDRD15 SETX RNGTT ACACB EFCAB6 MKS1 SH3BP4 SLFN13 PI4KA EHD1 VPS13A GCC1 | 2.75e-06 | 777 | 101 | 12 | 35844135 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | RNGTT IPO8 POLD1 PSMA2 XPO4 HMMR MKS1 NUP205 SH3BP4 SF3B6 IFT122 EIF3D FGD6 IQGAP3 SORL1 | 6.35e-06 | 1321 | 101 | 15 | 27173435 |
| Pubmed | SETX RNGTT ACTR5 POLD1 FARSB HMMR LNPEP PI4KA MORF4L1 SF3B6 ANKRD11 EIF3D ALDH3A2 IQGAP3 STAG2 KIF22 | 6.47e-06 | 1497 | 101 | 16 | 31527615 | |
| Pubmed | RNGTT IPO8 PSMA2 MRPL55 FARSB PSME2 NUP205 MORF4L1 SHCBP1 VPS35 ANP32A EIF3D ALDH3A2 CPVL MRPL1 | 7.20e-06 | 1335 | 101 | 15 | 29229926 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 8.35e-06 | 2 | 101 | 2 | 16565498 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 15998580 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 32966336 | ||
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 8.35e-06 | 2 | 101 | 2 | 7373044 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 19062096 | ||
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 8.35e-06 | 2 | 101 | 2 | 3696167 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 8.35e-06 | 2 | 101 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 8.35e-06 | 2 | 101 | 2 | 16098595 | |
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 8.35e-06 | 2 | 101 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 8.35e-06 | 2 | 101 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 8.35e-06 | 2 | 101 | 2 | 17645767 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 8.35e-06 | 2 | 101 | 2 | 15787745 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 12207352 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 17097635 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 30026462 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 6559257 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 8.35e-06 | 2 | 101 | 2 | 27758680 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 22387014 | ||
| Pubmed | Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects. | 8.35e-06 | 2 | 101 | 2 | 34299197 | |
| Pubmed | Assessment of complement C4 gene copy number using the paralog ratio test. | 8.35e-06 | 2 | 101 | 2 | 20506482 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 12480675 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 26800705 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 8.35e-06 | 2 | 101 | 2 | 23749435 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23918728 | ||
| Pubmed | Murine complement C4 is not required for experimental autoimmune encephalomyelitis. | 8.35e-06 | 2 | 101 | 2 | 15390104 | |
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 8.35e-06 | 2 | 101 | 2 | 3037333 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 11726230 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 4216347 | ||
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 8.35e-06 | 2 | 101 | 2 | 1699796 | |
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 8.35e-06 | 2 | 101 | 2 | 6950384 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 8.35e-06 | 2 | 101 | 2 | 2997024 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 8660986 | ||
| Pubmed | Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences. | 8.35e-06 | 2 | 101 | 2 | 3624865 | |
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 8.35e-06 | 2 | 101 | 2 | 8428773 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 21857912 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 24638111 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 6208559 | ||
| Pubmed | The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement. | 8.35e-06 | 2 | 101 | 2 | 4514997 | |
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 8.35e-06 | 2 | 101 | 2 | 21345967 | |
| Pubmed | The inheritance of susceptibility to the Gross leukemia virus in mice. | 8.35e-06 | 2 | 101 | 2 | 5919331 | |
| Pubmed | An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene. | 8.35e-06 | 2 | 101 | 2 | 3167981 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 7545960 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 30041577 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 2572548 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 2302180 | ||
| Pubmed | Complete cDNA sequence of the fourth component of murine complement. | 8.35e-06 | 2 | 101 | 2 | 3862104 | |
| Pubmed | The BS variant of C4 protects against age-related loss of white matter microstructural integrity. | 8.35e-06 | 2 | 101 | 2 | 34358307 | |
| Pubmed | Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d. | 8.35e-06 | 2 | 101 | 2 | 18360261 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 8.35e-06 | 2 | 101 | 2 | 18091514 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 29080553 | ||
| Pubmed | Schizophrenia risk from complex variation of complement component 4. | 8.35e-06 | 2 | 101 | 2 | 26814963 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 8.35e-06 | 2 | 101 | 2 | 25339671 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 17728371 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 6149580 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 6149581 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 12115608 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 3542363 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 2387317 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 8132550 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 2395880 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 26814708 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 6192448 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 6167582 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 16908004 | ||
| Pubmed | Slp is an essential component of an EDTA-resistant activation pathway of mouse complement. | 8.35e-06 | 2 | 101 | 2 | 1438267 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 7365238 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 19150565 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 7391573 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 17506029 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 17971360 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23715124 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 3464002 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 2993295 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 8.35e-06 | 2 | 101 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 8.35e-06 | 2 | 101 | 2 | 17971229 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 6881182 | ||
| Pubmed | Identification of the site of sulfation of the fourth component of human complement. | 8.35e-06 | 2 | 101 | 2 | 3944109 | |
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 8.35e-06 | 2 | 101 | 2 | 17921792 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 8.35e-06 | 2 | 101 | 2 | 6978711 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 35898513 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 33353966 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 21733561 | ||
| Interaction | S1PR4 interactions | 5.81e-06 | 137 | 101 | 7 | int:S1PR4 | |
| Cytoband | 2p16.2 | 1.71e-04 | 9 | 101 | 2 | 2p16.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q11 | 3.12e-04 | 12 | 101 | 2 | chr16q11 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 2.62e-04 | 31 | 73 | 3 | 81 | |
| GeneFamily | Complement system|Sushi domain containing | 4.10e-04 | 36 | 73 | 3 | 492 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 4.45e-04 | 37 | 73 | 3 | 454 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 5.68e-04 | 9 | 73 | 2 | 1234 | |
| GeneFamily | Proteasome | 6.94e-04 | 43 | 73 | 3 | 690 | |
| GeneFamily | Aminopeptidases|CD molecules | 2.10e-03 | 17 | 73 | 2 | 104 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.41e-03 | 66 | 73 | 3 | 722 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.74e-08 | 198 | 101 | 8 | 844f534551483c89ef789d1cfeb4680e54f794b2 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.74e-08 | 198 | 101 | 8 | e36303628af3139310c1d7a84d2919b7319bbda4 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 3.73e-07 | 200 | 101 | 7 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_ALM_Oprk1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.90e-06 | 162 | 101 | 6 | 2d28306c6125b31f11ea6d911a167b93a74907c5 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-06 | 173 | 101 | 6 | 6c9ecf77d2fb0f89100fdd7e4e88f85598278bc7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.60e-06 | 181 | 101 | 6 | 6873c1138b28c130637d06b64981ad11c262e85f | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-06 | 181 | 101 | 6 | b203b616584cdbd0bbb0e382b2916d0bd49d3526 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-06 | 181 | 101 | 6 | c748c16fd20d1949d33ff6290dc9d9016c4dc86c | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 182 | 101 | 6 | 39f9b3eb22293cc27c6e175702c77d1eeb24fdc9 | |
| ToppCell | P28-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.72e-06 | 182 | 101 | 6 | db5d6c5e7d59734653906b126f2c1d57461a5290 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-06 | 183 | 101 | 6 | 83592c332b1e82673f993d37c7f480befdc3dcda | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.96e-06 | 184 | 101 | 6 | d1e0e3b0eed2db8a5b7e3d6f81294667e4ba64e5 | |
| ToppCell | 390C-Myeloid-Macrophage|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.76e-06 | 190 | 101 | 6 | f933d971f092c4e56e9f670a9205b688c8b1ca28 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l12-14|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.06e-06 | 192 | 101 | 6 | 52d0aa51e3b6ab3608a5f40bdde9f8134b3afd94 | |
| ToppCell | Monocytes-Tissue-resident_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 5.21e-06 | 193 | 101 | 6 | 198552810dcac8d0ca63a78badd6702b49ff6edf | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-06 | 193 | 101 | 6 | 6a9bce5064938b5b84ad57b4fd4a7841afe100c8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.36e-06 | 194 | 101 | 6 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.69e-06 | 196 | 101 | 6 | 34bd155e6d848eb53d613997c0e244535de30ba3 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.86e-06 | 197 | 101 | 6 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.21e-06 | 199 | 101 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 6.39e-06 | 200 | 101 | 6 | 8f8b8c225cdc79baf16fe04be89bdb65e404a055 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells|10w / Sample Type, Dataset, Time_group, and Cell type. | 6.39e-06 | 200 | 101 | 6 | a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.39e-06 | 200 | 101 | 6 | a1503bcc774bed9563eda7cf90b8b5bf4405ad85 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.39e-06 | 200 | 101 | 6 | 25247f8b6ba6cd899ba6bd47e28e090d697e4632 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Sla|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.27e-05 | 132 | 101 | 5 | ddebc0b233fdbb73ceb70187945bbed8fd273f2a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-05 | 140 | 101 | 5 | e64f6aa57bc069cfe970089bd1c298433bfaf771 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.62e-05 | 164 | 101 | 5 | 0662cd9d21608efacc336e0a582859f3b9a4951d | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-05 | 168 | 101 | 5 | 0e8b0e6399c6c82c9c0e546f7316f902de0765d3 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.17e-05 | 169 | 101 | 5 | 563c267edaade0e5df192ad953801ef9768d4270 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 4.17e-05 | 169 | 101 | 5 | bea8aba1f3cc3d0e8d448c1c45f5354d26ebf850 | |
| ToppCell | mild-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.41e-05 | 171 | 101 | 5 | 5c8198182495bda7a826e9d80aa467f4eb1094ec | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|ILC / Donor, Lineage, Cell class and subclass (all cells) | 4.54e-05 | 172 | 101 | 5 | 4977e1f4deae781750e27a8054deccd336cfb74a | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P2-Tnr|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.61e-05 | 87 | 101 | 4 | 0c3a3ed1f279ed29a0113cc73ae590157a4b7334 | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4_(Bmp4)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.61e-05 | 87 | 101 | 4 | 5d1dbbd86d82cbce4f2a3365242eb92d9c821a9e | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.61e-05 | 87 | 101 | 4 | a93dbe73b337cc2d93208822728b9badf30b6870 | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4_(Bmp4)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.61e-05 | 87 | 101 | 4 | 45ef27ba84f731e4b2188813cd6931950e5164ac | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_2|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.79e-05 | 174 | 101 | 5 | a75ba49ccea6bd3d78ada1092b46deb5202c58a5 | |
| ToppCell | droplet-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.06e-05 | 176 | 101 | 5 | b17317ac41d3215db55a38cbd3366c0947f7a2a3 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.06e-05 | 176 | 101 | 5 | 45c6983ab671b0f306e7390320bd84f848e474cc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.48e-05 | 179 | 101 | 5 | 55bc69f107fc710db7617c428575792adfdbbcc1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.93e-05 | 182 | 101 | 5 | c6b3762ccec326f057819f75fa7fac0145fb7d54 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.09e-05 | 183 | 101 | 5 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 6.25e-05 | 184 | 101 | 5 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | P28-Endothelial|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.25e-05 | 184 | 101 | 5 | b056411f499866097f4322999cfd1e57a3927b78 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-T_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 184 | 101 | 5 | 185b49630da61cbf45c0926d1b992943296d2a54 | |
| ToppCell | P28-Endothelial-capillary_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.57e-05 | 186 | 101 | 5 | 26a625ca0300055d6af3472aa0bfba59b73db292 | |
| ToppCell | proximal-3-Hematologic-Myeloid_Dendritic_Type_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.57e-05 | 186 | 101 | 5 | c920dffd24f051b54d8b48f801fffc928d99e135 | |
| ToppCell | proximal-Hematologic-Myeloid_Dendritic_Type_1-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.57e-05 | 186 | 101 | 5 | d740aca5dc4240851ba7bc5988c0970d785ad0c2 | |
| ToppCell | Tuft|World / Class top | 6.57e-05 | 186 | 101 | 5 | f4d83f15ab7b49c0920a322cd832413ece7c9948 | |
| ToppCell | proximal-Hematologic-Myeloid_Dendritic_Type_1|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.57e-05 | 186 | 101 | 5 | 4ca7f6c043874a0c536f75af5ca24c7c66725e54 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-05 | 187 | 101 | 5 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.74e-05 | 187 | 101 | 5 | e61c1755531469dd3850c9740474b5ad4e0499c1 | |
| ToppCell | Tuft-tuft-2|World / Class top | 6.74e-05 | 187 | 101 | 5 | 4ec6eee866619dfe13c84f5d2e812bb380d37139 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 187 | 101 | 5 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | 6.91e-05 | 188 | 101 | 5 | b240ea20750ffb825cb5fe41d06c632233406ab6 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-Cycling_Dendritic|lymph-node_spleen / Manually curated celltypes from each tissue | 6.91e-05 | 188 | 101 | 5 | 723348a1836a074e068320cb736ce6a953e0038f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD|kidney_cells / Celltypes from Cells and Nuclei per compartment and clinical group | 6.91e-05 | 188 | 101 | 5 | 90188b60ff893754f7938fe8edab79758827168e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-05 | 189 | 101 | 5 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-05 | 189 | 101 | 5 | e11998c57609c5714705713ac3a32016d6d841dd | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-05 | 189 | 101 | 5 | 5a0fd34928117f162c83ca1b068aa8f7069a6765 | |
| ToppCell | 390C-Myeloid-Macrophage-FABP4+_Macrophage_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.09e-05 | 189 | 101 | 5 | 3b5e1a8d5c1e1fa2124f64f212e9c6b8f1b7d7da | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-05 | 190 | 101 | 5 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.27e-05 | 190 | 101 | 5 | 06bfb62b94b0faf467ef93d5bc5d08924c770098 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.27e-05 | 190 | 101 | 5 | 63018acb7ad80415e861643162abdc2e55968ee4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-05 | 190 | 101 | 5 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-05 | 190 | 101 | 5 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_2|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.27e-05 | 190 | 101 | 5 | 6514f00d222eef08c282face7f177259bca62f0e | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.27e-05 | 190 | 101 | 5 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 7.27e-05 | 190 | 101 | 5 | 451eaceb0cb0ec6cfcae00253c0e5c92a168c2f3 | |
| ToppCell | Endothelial-D_(cycle)|World / shred on cell class and cell subclass (v4) | 7.45e-05 | 191 | 101 | 5 | 49a4d8f181558e3be9527a8ff9a178f3bb01323c | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.45e-05 | 191 | 101 | 5 | d6e158f16a183c9203c057192342e9b83e79bc89 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.45e-05 | 191 | 101 | 5 | 7cb5c6f2cf27f3503d1b313e402a7410dfe6473e | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.45e-05 | 191 | 101 | 5 | a2c235a55094e4fd5273d764c9e2967116b48c23 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.64e-05 | 192 | 101 | 5 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.64e-05 | 192 | 101 | 5 | e19e3e8edcc08e4a67873bfb6e46489ca6c8756a | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.64e-05 | 192 | 101 | 5 | 61c2caf6c838132ed5faa8791c288f2149eba2c8 | |
| ToppCell | P07-Endothelial-proliferative_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.82e-05 | 193 | 101 | 5 | 1e95ef29357969ee385b4717c0b5a497390ac260 | |
| ToppCell | Severe_COVID-19-Myeloid-proliferating_Myeloid_cells|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 7.82e-05 | 193 | 101 | 5 | 0d85025690c9cd545cba30abc38acbdd6a39b153 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.82e-05 | 193 | 101 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.82e-05 | 193 | 101 | 5 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.82e-05 | 193 | 101 | 5 | 33349830e9eba506470ad3661fad5e5a283d20ca | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.82e-05 | 193 | 101 | 5 | 2d0dd2671ff27b922eb316f1ed0140353536ef30 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.82e-05 | 193 | 101 | 5 | f20b90e3f3f5c9a1ae51c5ebe6d3adb954a142f2 | |
| ToppCell | P07-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.82e-05 | 193 | 101 | 5 | 0f21fb8b35f89f4c1c8109d1a4d3d08a452f9edd | |
| ToppCell | P03-Endothelial-proliferative_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.02e-05 | 194 | 101 | 5 | 22bcfb0f3f73608feb22c0847ab4d34f87aeede0 | |
| ToppCell | (3)_Chondrocytes-(33)_Chondro-prol/rest|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis | 8.02e-05 | 194 | 101 | 5 | 4a207630d72059345b10010f5cfd3b1462458324 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.02e-05 | 194 | 101 | 5 | cb39850e9577015b6b9834e98c36b412bae7d462 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.02e-05 | 194 | 101 | 5 | 408597c9aa302a44b112c1d612c21fbb0227a82a | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.02e-05 | 194 | 101 | 5 | 193cc20fefbd795a4ad59e401a95af47d30603e7 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-05 | 194 | 101 | 5 | 0797245ebfa389a6f66874cb0f11297f1456e600 | |
| ToppCell | P03-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.02e-05 | 194 | 101 | 5 | 5e56ce9b9fe0721be3a9e6efe1422599bb867721 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.02e-05 | 194 | 101 | 5 | 2360b5f995b360419de41612368cab9fb61781a1 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.02e-05 | 194 | 101 | 5 | 903ae11708b0cb24538c6982abd57fe6fa95b8d3 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.02e-05 | 194 | 101 | 5 | 58406502a8cbcc3037f79a1b6a683df408297ae5 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.02e-05 | 194 | 101 | 5 | 3a49c7c86036e09a8cd0114988380d04ad1a26fb | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-05 | 194 | 101 | 5 | 0241b4b88d6210b4c1b8aa99db17115b18142f01 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 8.21e-05 | 195 | 101 | 5 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.21e-05 | 195 | 101 | 5 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.21e-05 | 195 | 101 | 5 | b57132802cb977551e214880984f3edcd375474f | |
| ToppCell | VE-granulo1-|VE / Condition, Cell_class and T cell subcluster | 8.41e-05 | 196 | 101 | 5 | ab3f2ce294c7e503d86254a195be0cf500a2c5e4 | |
| Disease | endoplasmic reticulum aminopeptidase 2 measurement | 1.09e-05 | 2 | 98 | 2 | EFO_0801566 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 1.26e-05 | 14 | 98 | 3 | EFO_0004611, EFO_0008589 | |
| Disease | Colorectal Carcinoma | ABCC4 POLD1 PSMA2 LY96 NCDN ARHGEF10L SACS ANP32A VPS13A SLC29A1 SORL1 | 2.19e-05 | 702 | 98 | 11 | C0009402 |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 3.27e-05 | 3 | 98 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | hydrocephalus (implicated_via_orthology) | 3.31e-05 | 19 | 98 | 3 | DOID:10908 (implicated_via_orthology) | |
| Disease | response to statin | 3.68e-05 | 56 | 98 | 4 | GO_0036273 | |
| Disease | longevity, healthspan, parental longevity | 1.22e-04 | 29 | 98 | 3 | EFO_0004300, EFO_0007796, EFO_0009762 | |
| Disease | Complement deficiency disease | 1.80e-04 | 33 | 98 | 3 | C0272242 | |
| Disease | Cerebral ventriculomegaly | 2.27e-04 | 7 | 98 | 2 | C1531647 | |
| Disease | Hydrocephalus Ex-Vacuo | 2.27e-04 | 7 | 98 | 2 | C0270720 | |
| Disease | Communicating Hydrocephalus | 2.27e-04 | 7 | 98 | 2 | C0009451 | |
| Disease | endoplasmic reticulum aminopeptidase 1 measurement | 2.27e-04 | 7 | 98 | 2 | EFO_0008119 | |
| Disease | Fetal Cerebral Ventriculomegaly | 2.27e-04 | 7 | 98 | 2 | C2936718 | |
| Disease | Post-Traumatic Hydrocephalus | 2.27e-04 | 7 | 98 | 2 | C0477432 | |
| Disease | Obstructive Hydrocephalus | 2.27e-04 | 7 | 98 | 2 | C0549423 | |
| Disease | aspirin use measurement | 2.98e-04 | 39 | 98 | 3 | EFO_0007013 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 3.02e-04 | 8 | 98 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | severe pre-eclampsia (is_marker_for) | 3.02e-04 | 8 | 98 | 2 | DOID:13129 (is_marker_for) | |
| Disease | Congenital Hydrocephalus | 3.02e-04 | 8 | 98 | 2 | C0020256 | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 3.02e-04 | 8 | 98 | 2 | DOID:4783 (biomarker_via_orthology) | |
| Disease | Aqueductal Stenosis | 3.02e-04 | 8 | 98 | 2 | C2936786 | |
| Disease | Hydrocephalus | 3.87e-04 | 9 | 98 | 2 | C0020255 | |
| Disease | triglycerides in large LDL measurement | 3.98e-04 | 43 | 98 | 3 | EFO_0022319 | |
| Disease | coronary artery disease, factor VII measurement | 5.22e-04 | 111 | 98 | 4 | EFO_0001645, EFO_0004619 | |
| Disease | brain aneurysm | 5.58e-04 | 113 | 98 | 4 | EFO_0003870 | |
| Disease | factor VIII measurement, coronary artery disease | 5.58e-04 | 113 | 98 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | factor XI measurement, coronary artery disease | 5.96e-04 | 115 | 98 | 4 | EFO_0001645, EFO_0004694 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 6.57e-04 | 118 | 98 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | triglycerides in LDL measurement | 8.67e-04 | 56 | 98 | 3 | EFO_0022320 | |
| Disease | response to statin, LDL cholesterol change measurement | 1.11e-03 | 15 | 98 | 2 | EFO_0007804, GO_0036273 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 1.22e-03 | 63 | 98 | 3 | EFO_0001645, EFO_0004792 | |
| Disease | Antibody Deficiency Syndrome | 1.44e-03 | 17 | 98 | 2 | C0003257 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 1.44e-03 | 17 | 98 | 2 | EFO_0022232 | |
| Disease | atrial fibrillation | 1.51e-03 | 371 | 98 | 6 | EFO_0000275 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 1.61e-03 | 18 | 98 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 1.72e-03 | 71 | 98 | 3 | EFO_0001645, EFO_0004791 | |
| Disease | fibrinogen measurement, coronary artery disease | 1.76e-03 | 154 | 98 | 4 | EFO_0001645, EFO_0004623 | |
| Disease | Paroxysmal atrial fibrillation | 1.85e-03 | 156 | 98 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 1.85e-03 | 156 | 98 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.85e-03 | 156 | 98 | 4 | C2585653 | |
| Disease | Atrial Fibrillation | 2.03e-03 | 160 | 98 | 4 | C0004238 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 2.31e-03 | 166 | 98 | 4 | EFO_0004530, EFO_0004611 | |
| Disease | Immunologic Deficiency Syndromes | 2.64e-03 | 23 | 98 | 2 | C0021051 | |
| Disease | level of Sphingomyelin (d40:2) in blood serum | 2.64e-03 | 23 | 98 | 2 | OBA_2045181 | |
| Disease | mortality | 2.69e-03 | 173 | 98 | 4 | EFO_0004352 | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 2.87e-03 | 24 | 98 | 2 | DOID:10595 (implicated_via_orthology) | |
| Disease | airway responsiveness measurement | 2.87e-03 | 24 | 98 | 2 | EFO_0006897 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.98e-03 | 86 | 98 | 3 | EFO_0008595, EFO_0020945 | |
| Disease | pulmonary embolism | 3.12e-03 | 25 | 98 | 2 | EFO_0003827 | |
| Disease | TEMPS-A questionnaire | 3.12e-03 | 25 | 98 | 2 | EFO_0004783 | |
| Disease | Cardiac Arrhythmia | 3.12e-03 | 25 | 98 | 2 | C0003811 | |
| Disease | large artery stroke, coronary artery disease | 3.12e-03 | 25 | 98 | 2 | EFO_0001645, EFO_0005524 | |
| Disease | Kidney Diseases | 3.18e-03 | 88 | 98 | 3 | C0022658 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KLILYPNKNVYQILF | 476 | Q5W0A0 | |
| YVLVALNQFRYLPLE | 86 | Q15303 | |
| YVESLKRILQDYRNP | 331 | Q9HCE6 | |
| NPYFEYLQIRKKIEE | 2436 | Q6UB99 | |
| LRPVLYNYLDKNLTV | 851 | P0C0L5 | |
| RAILQFYPKYVELIN | 796 | P12821 | |
| LYKNLDLILPTLRNY | 766 | O60242 | |
| LLPQYLEIYIIVEKA | 181 | Q9Y3Q7 | |
| ILAKLLPQYLDQDLY | 146 | P51648 | |
| YRENVFKLLPQLTYL | 131 | P39687 | |
| TLQYILDRYPKDIQE | 471 | Q9H9F9 | |
| LPLDYKLERQYVLAV | 671 | Q9HCU4 | |
| LEVFYKLLRDYEPQL | 766 | Q92621 | |
| QLLYKFERPQYAEIL | 271 | Q9UBU8 | |
| AYIVDGLRQYKQPIL | 2176 | O00763 | |
| YYAEDLRLKLPLQEL | 181 | Q6IWH7 | |
| VIDQLREFYRPYNIK | 341 | Q9Y278 | |
| QYLKDYLTRLLVPYV | 341 | Q12891 | |
| YQRYKEELVPFLLKL | 481 | O00370 | |
| LAIQLPEKILIYELY | 401 | Q9HBG6 | |
| DLVKLKYLEYRQVPN | 251 | O15480 | |
| QLLPFLVRYAKTLYE | 416 | Q9UBB6 | |
| VPRYLIYDIIKFNSQ | 356 | O60942 | |
| ETIYKNYYRIQLKPE | 631 | Q7L2J0 | |
| ILYPAITKYEKRLQN | 526 | Q5CZC0 | |
| QLYYVKFLSLPEVRQ | 326 | Q9H3G5 | |
| YLEIYQEKVLDLLDP | 176 | Q14807 | |
| AIEIYLKLYDNPLTN | 561 | Q6N069 | |
| LFYIPQIVQALRYDK | 1651 | P42356 | |
| LPGVAYYNKLIDRLQ | 471 | P09848 | |
| NYFEIQYPLKKLDLV | 406 | Q9UIQ6 | |
| EVYIDLLQKNRTPYV | 26 | Q9BSJ2 | |
| LYLRKVLPLEEAYRF | 31 | Q9H223 | |
| ETVQRILLEPYKYLL | 6 | O95749 | |
| PLKKIYDVEQLRYQA | 81 | Q86VI3 | |
| GLEVKPILNYYRENI | 616 | P53708 | |
| QIVALAKILLDPYYR | 416 | Q9NYA4 | |
| LLYEELYNKTKPFQL | 581 | O75330 | |
| RLKEYDEPYVLLQNK | 1251 | O15439 | |
| LPVVNYNLLKYICRF | 256 | Q8N264 | |
| QIDLPIKRYREYELV | 31 | O15072 | |
| EYLKNIIYRFLTLPD | 721 | Q96CN9 | |
| KIQLPEYILDFGYII | 1591 | Q4G0P3 | |
| VPLLEKYLYALGQNR | 181 | A2RU49 | |
| YIDGLNNLIYRPKIL | 346 | Q9UBX8 | |
| NNLIYRPKILVDRLY | 351 | Q9UBX8 | |
| QYLSQVLKESLRLYP | 351 | Q9Y6A2 | |
| LYFILNDLNKINPVY | 3661 | Q9UFH2 | |
| RLFPQKDIYLVEYSL | 36 | Q9P109 | |
| YLKIVLDTFVYQIPR | 321 | Q5THR3 | |
| YLILKDPNKQVIRVY | 506 | O15371 | |
| IPRRDLKQLYFNLYI | 66 | Q9Y6Y9 | |
| NLKRYLLQYFKPVID | 721 | Q6P179 | |
| VQRIPRYELLLKEYI | 246 | Q7Z6J4 | |
| RQLYAQKLLPLEEHY | 26 | Q9H4M9 | |
| AYVELLIQLKKRYFP | 2921 | Q9NZJ4 | |
| ESLRKLIQYPYLQAF | 81 | Q68D06 | |
| YYLEQQLAKPLLRIF | 956 | P28340 | |
| EFLQRVKRLPLEYSY | 316 | P07358 | |
| LRPVLYNYLDKNLTV | 851 | P0C0L4 | |
| QNLFPLEINRAIYYK | 111 | Q13029 | |
| PFKLEKLVDNYYRLV | 391 | Q9Y5H4 | |
| LKILDQYRQKEYVAP | 306 | O15397 | |
| TLNPVYNEILRYKIE | 691 | Q9HCH5 | |
| LNDVIIDFYLKYLIL | 776 | Q9BQF6 | |
| KDEQYLFLVRVVVPY | 1901 | Q92673 | |
| LEQILRPCKFLTYIY | 741 | Q9P0V3 | |
| LPYALLQEVYKLEDV | 4701 | Q8WXH0 | |
| FYIRYSEIINLKVVP | 1821 | B5MCY1 | |
| NLEELPLNEYREYIK | 211 | Q9BRQ8 | |
| ALNLIYKPYQIRILD | 216 | Q9Y274 | |
| EILKYPYLLLHERVN | 116 | Q7Z333 | |
| FLYRFLPQKIIYLNQ | 31 | Q9UL46 | |
| LIENPLLRYVFGYQK | 301 | Q8NEM2 | |
| VLYKIDVPANRYDLL | 61 | Q9NSD9 | |
| LPRLEFYRYYQQLKL | 226 | Q99808 | |
| LYQKVLLYQPFELRE | 1766 | Q8IY92 | |
| RALQFYLDYKPLLIN | 1406 | P53675 | |
| KEVRFFNLQVLYPLL | 196 | Q9GZS9 | |
| LYQRNRPVDYFVLLL | 661 | Q9NRU3 | |
| LYQRNKPVDYFVLIL | 676 | Q9H8M5 | |
| LPQYRLKVDTLFLYE | 51 | O60296 | |
| VYLKRLYPRQIYEVE | 86 | Q9BYD6 | |
| QLEILYEKYLLDSNP | 2571 | Q86UP3 | |
| FLLTYVLQRPNLQKY | 96 | Q9C0E2 | |
| ILLRNLLPYKIAYYI | 2111 | Q96RL7 | |
| SPLDYQYRQEILKLE | 101 | Q9NXB0 | |
| FISPEELIKKLQYRY | 726 | Q13905 | |
| QAYARLYPVLLVKQD | 46 | Q7Z7F7 | |
| TNLLQLPQYFDLEIY | 586 | Q8N3U4 | |
| ELVQYAGNIIPRLYL | 96 | Q96QK1 | |
| EVNRILYIRNLPYKI | 16 | Q9Y3B4 | |
| PVIEDRILNQILYYL | 911 | Q6ZV73 | |
| RILNQILYYLPQLYE | 916 | Q6ZV73 | |
| ILYYLPQLYELNRDL | 921 | Q6ZV73 | |
| KRNIFDYYEPLIKQI | 2046 | Q9HCK1 | |
| RKLAQQYYLVYQEPI | 91 | P25787 | |
| TYELRPYLDLLFQIL | 2331 | O00507 | |
| EIVYNKLLPYAERLD | 31 | Q14997 | |
| YLIIKYPFREHLLQK | 121 | Q9BXA5 | |
| YTEKPLYENLRDILL | 311 | Q99986 | |
| NPYFRNKLIVKVYEV | 301 | Q8N831 | |
| LYQKIRILEKPFEYI | 206 | P17014 | |
| FEAIIQYPILLKDYR | 911 | Q96C45 | |
| IRYYFENLKISIPQI | 3981 | Q5THJ4 |